Related Experiment Video
Updated: Jan 15, 2026
Temporomandibular Joint Pain Measurement by Bite Force and Von Frey Filament Assays in Mice
Published on: September 13, 2024
Immunohistochemical Profiling in Temporomandibular Disorders: A Systematic Review of Biomarker Patterns in Synovial
Pascal Eber1,2, Yannick M Sillmann1, Ana M P Baggio1
1Division of Oral and Maxillofacial Surgery, Massachusetts General Hospital; Department of Oral and Maxillofacial Surgery, Harvard School of Dental Medicine, Boston, Massachusetts, USA.
Background:
Temporomandibular disorders (TMD) are multifactorial conditions involving biomechanical dysfunction and progressive degeneration of the temporomandibular joint (TMJ) and surrounding tissues. Although affecting up to 36% of the population, their underlying molecular mechanisms remain incompletely understood. Immunohistochemical analysis of synovial biomarkers may help clarify processes involved in tissue degeneration and symptom development.
Objective:
This systematic review investigates associations between immunohistochemical biomarkers in synovial tissue and morphological or symptomatic findings in TMD, with a focus on internal derangement and disc displacement.
Methods:
A comprehensive literature search was conducted in MEDLINE/PubMed, EMBASE, Web of Science, and selected journals. Studies were screened according to PRISMA guidelines, and methodological quality was assessed using the Newcastle-Ottawa Scale. Due to heterogeneity across studies, a narrative synthesis was performed.
Results:
Thirteen studies involving 493 patients (mean age: 42.2 years; 82% women) were included, analyzing 23 different biomarkers. Frequently examined markers included MMPs, COX-2, iNOS, interleukins, and VEGF. Several of these showed statistically significant correlations with histological, radiological, or clinical findings, suggesting roles in joint homeostasis, inflammation, and tissue remodeling associated with TMD.
Conclusion:
Based on the reported associations with histological, radiological, and clinical findings, biomarkers were categorised into stage-specific and functional groups, underscoring their relevance for disease stratification and prognosis. By revealing disease-related patterns in progression and severity, synovial biomarkers have the potential to empower our understanding of the underlying mechanisms of TMD and contribute to more precise diagnostic and therapeutic approaches.
